LP Area »
  • Home
  • About Us
  • Our Team
  • Portfolio Companies
  • News
  • Contact Us

Venture Investors


SubscribeIn the News

INVIRAGEN: VACCINES IN DEVELOPMENT TO PROTECH AGAINST DENGUE FEVER

Tuesday, December 13th, 2011 | Healthcare

NANOBIO SIGNS PRECLINICAL COLLABORATION PACT WITH MERCK FOR RSV VACCINE

Monday, December 12th, 2011 | Healthcare

INVIRAGEN PRESENTS SAFETY AND IMMUNE RESPONSE DATA FROM A PHASE 1 STUDY OF ITS TWO-DOSE DENGUE VACCINE, DENVAX

Wednesday, December 7th, 2011 | Healthcare

EUTHYMICS BIOSCIENCE SHOWS PROMISE WITH ADHD DRUG

Wednesday, December 7th, 2011 | Healthcare

NOVELOS THERAPEUTICS PRICES $5.9M PUBLIC OFFERING

Thursday, December 1st, 2011 | Healthcare

NOVELOS THERAPEUTICS PRICES $5.9M PUBLIC OFFERING

Thursday, December 1st, 2011 | Healthcare

CHROMATIN: AREA RANCHERS GROW FEEDSTOCK FOR BIOFUEL

Wednesday, November 30th, 2011 | Clean Tech
« Previous Entries Next Entries »

Categories

  • Venture Investors
  • Healthcare
  • Technology
  • Clean Tech

Archive

  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006

Search

 
©2012 Venture Investors LLC, All Rights Reserved
  • Home
  • About Us
  • Our Team
  • Portfolio Companies
  • News
  • Contact Us